Clinical Trials Sponsored by Yok Lam Kwong

Total 71 results

Frances Kam Yuet WONG

Completed

Effects of Health-social Partnership Programme

Health Behavior

Hong Kong
The Hong Kong Polytechnic University
The University of Hong Kong; Kwong Wah Hospital; University of Glasgow; Tsan Yuk...

Recruiting

mHealth Intervention to Reduce Maternal Postnatal Depression and Promote Family Health

Quality of Life | Family Relations | Postnatal Depression

Hong Kong
Lai Fun HO, PhD
Chinese University of Hong Kong

Recruiting

Electroacupuncture With or Without Combined Warm Needling for Tinnitus

Tinnitus, Subjective | Tinnitus

China
Stephen Chan Lam

Recruiting

CXD101 in Immunotherapy-related Liver Cancer

HCC

Hong Kong
Stephen Chan Lam

Active, not recruiting

Cabozantinib in Hepatocellular Carcinoma

HCC

Korea, Republic of, Hong Kong
Zai Lab (Hong Kong), Ltd.

Recruiting

A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP (public)

Community-acquired Bacterial Pneumonia

United States
Vincent Mok

Recruiting

Neurodegenerative Diseases Registry (NDD Registry)

Parkinson Disease | Neurodegenerative Diseases | Multiple System Atrophy | Progressive Supranuclear Palsy

Hong Kong
The Hong Kong Polytechnic University
Pok Oi Hospital

Recruiting

VR Motor-cognitive Training for Older People With Cognitive Frailty

Physical Function | Cognitive Frailty

Hong Kong
The University of Hong Kong
Chinese University of Hong Kong; City University of Hong Kong; York University

Not yet recruiting

Cognitive Behavioural Couple Intervention Therapy for Chinese Couples With a Depressed Partner

Depression

Hong Kong
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient

Platinum-sensitive Relapsed Ovarian Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study to Assess the Efficacy and Safety of DCC-2618 and Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumors After Treatment With Imatinib

Gastrointestinal Stromal Tumor(GIST)

China
Zai Lab (Shanghai) Co., Ltd.

Terminated

MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients

Advanced Hepatocellular Carcinoma (HCC)

China
Zai Lab (Shanghai) Co., Ltd.

Terminated

A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma

Unresectable, Recurrent or Metastatic Melanoma | Untreated Mucosal or Acral Lentiginous Melanoma

China
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC

Breast Cancer Metastatic

Taiwan
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST)

Gastrointestinal Stromal Tumors

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study of Niraparib in Patients With Relapsed Ovarian Cancer

Ovarian Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Completed

To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid Malignancies

Solid Malignancies

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Trial of ZL-1201 in Subjects With Advanced Cancer

Advanced Cancer

United States, China
Zai Lab (Shanghai) Co., Ltd.

Terminated

A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment

Gastric Cancer | Triple Negative Breast Cancer | Endometrial Carcinoma | Biliary Tract Carcinoma

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study to Evaluate the Pharmacokinetics of Margetuximab in Chinese Patients With HER2+ MBC

HER2 Positive Metastatic Breast Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer

Ovarian Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Terminated

A Study of Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer

Extensive-stage Small Cell Lung Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC

Hepatocellular Carcinoma (HCC)

China
Zai Lab (Shanghai) Co., Ltd.

Completed

The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patients With Ovarian Cancer

Ovarian Cancer

China
Martin Lan

Completed

Brain Imaging to Understand the Role of Inflammation in N-Acetyl Cysteine (NAC) Treatment of Bipolar Depression

Depression | Bipolar Disorder

United States
Zai Lab (Shanghai) Co., Ltd.
Zai Lab (US) LLC

Recruiting

An Open-label, Multicenter Study of ZL-1310 in Subjects With Small Cell Lung Cancer

SCLC

United States
Education University of Hong Kong
LAU Ngar Sze

Active, not recruiting

Mindfulness Intervention and Online Social Networking

Mindfulness

Hong Kong
Kwang-Ha Yoo
Hanlim Pharm. Co., Ltd.

Completed

Evaluate the Efficacy and Safety of Acute Bronchitis Symptoms Improvement for Bronpass Tab. Compared to Erdos Capsule

Acute Bronchitis

Korea, Republic of
The University of Hong Kong
Lok Sin Tong Benevolent Society, Kowloon

Completed

Smoking Cessation Programme in Workplaces in Hong Kong (Phase IV)

Smoking Cessation

Hong Kong
The University of Hong Kong
Lok Sin Tong Benevolent Society, Kowloon

Completed

Promoting Tobacco Control and Smoking Cessation in Workplaces [Phase I]

Smoking

China
The University of Hong Kong
Lok Sin Tong Benevolent Society, Kowloon

Completed

Mindfulness Training for Smoking Cessation in Women in Workplaces

Smoking Cessation

China
Chinese University of Hong Kong
The University of Hong Kong; Queen Elizabeth Hospital, Hong Kong; North District... and other collaborators

Completed

Transurethral En Bloc Versus Standard Resection of Bladder Tumour

Bladder Cancer

Hong Kong
Hospital Authority, Hong Kong
Hoffmann-La Roche

Unknown

Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation | Graft vs Host Disease

China
The University of Hong Kong
Lok Sin Tong Benevolent Society, Kowloon

Active, not recruiting

Smoking Cessation Programme in Workplaces in Hong Kong (Phase Ⅴ)

Smoking Cessation

Hong Kong
The University of Hong Kong
Lok Sin Tong Benevolent Society, Kowloon

Unknown

Smoking Cessation in Workplaces in Hong Kong [Phase II]

Smoking

China
Zai Lab (Shanghai) Co., Ltd.
Mirati Therapeutics Inc.

Active, not recruiting

The Clinical Trial to Evaluate the Pharmacokinetics and Safety of MRTX849 in Patients With Advanced Solid Tumors

Advanced or Metastatic Solid Tumor

China
The University of Hong Kong
Lok Sin Tong Benevolent Society, Kowloon

Completed

Smoking Cessation Programme in Workplaces in Hong Kong (Phase III)

Smoking Cessation

Hong Kong
Zai Biopharmaceutical (Suzhou) Co., Ltd.

Recruiting

A Study of ZL-1211 in Patients With Advanced Solid Tumor

Advanced Solid Tumor

United States, China
Prof. HON Kam Lun Ellis

Completed

Effect of a Topical Spray on Itch Relief in Moderate-to-severe Childhood Eczema

Eczema

Hong Kong
Nam Dinh University of Nursing
The Hong Kong Polytechnic University

Completed

Effect of Qigong on the Symptom Clusters of Dyspnea, Fatigue, and Anxiety.

Lung Cancer, Nonsmall Cell | Lung Cancer Non-Small Cell Stage 0 | Lung Cancer, Nonsmall Cell, Stage I | Lung Cancer Non-Small Cell Stage II | Lung Cancer, Limited Stage Small Cell

Hong Kong
Chinese University of Hong Kong
Hoffmann-La Roche

Completed

A Study on Higher-dose Oseltamivir Treatment's Impact on Viral Clearance and Clinical Recovery in Adults Hospitalized With Influenza

Respiratory Tract Infections | Influenza

Hong Kong
Chinese University of Hong Kong
Hoffmann-La Roche

Completed

Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment

Chronic Hepatitis B

China
Chinese University of Hong Kong
GlaxoSmithKline; Hoffmann-La Roche

Completed

Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients

Chronic Hepatitis B

China
Tung Wah College
Chinese University of Hong Kong; Pok Oi Hospital; Golden Age Foundation

Not yet recruiting

Virtual Reality for Mental Well-being in Older People With Physical Disabilities

Mental Health Wellness 1 | Physical Disability
Vivian Wing Yan Lee
Hoffmann-La Roche; Queen Elizabeth Hospital, Hong Kong; Princess Margaret Hospital...

Terminated

Nursing and Pharmacy Time for Delivering Xeloda® Versus 5-Fluoruracil Regimens

Colorectal Cancer

Hong Kong
Vivian Wing Yan Lee
Hoffmann-La Roche; Queen Elizabeth Hospital, Hong Kong; Princess Margaret Hospital...

Withdrawn

Nursing and Pharmacy Care Between Capecitabine and 5-Fluoruracil Regimens

Gastric Cancer
The University of Hong Kong
Hong Kong Jockey Club Charities Trust; Lok Sin Tong Benevolent Society, Kowloon and other collaborators

Recruiting

Evaluation of Medication Management Service

Hypertension | Diabetes Mellitus, Type 2 | Medication Adherence | Polypharmacy | Medication Safety | High Risk Medications

Hong Kong
Dr. Annis Fung
University of Pennsylvania; The University of Hong Kong; Brooklyn College of...

Completed

Omega-3 Supplementation and Behavior Problems

Aggression | Antisocial Behavior | Antisocial Personality

China
Zai Lab (Hong Kong), Ltd.
Merck Sharp & Dohme LLC; Zai Biopharmaceutical (Shanghai) Co., Ltd.

Recruiting

A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors

Malignant Solid Tumor

United States, Spain
Vivian Wing Yan Lee
Hoffmann-La Roche; Pamela Youde Nethersole Eastern Hospital; Princess Margaret...

Completed

Cost-minimization Analysis of Gastric Cancer Treatments in Hong Kong

Gastric Cancer

Hong Kong

Clinical Trials Sponsored by Yok Lam Kwong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations